Provider 1780738757
NPI: 1780738757Share
Active Billing Period:2018-01→2024-11(83 months)
Extreme procedure concentration — 100% of $15.6M billed through a single code
Total Paid
$15.6M
$15,631,551
Total Claims
3,959
Beneficiaries
2,772
1.4 claims/patient
Avg Cost/Claim
$4K
Monthly Spending Trend
Yearly Spending
2018
$2.8M
+18%
2019
$3.3M
-34%
2020
$2.2M
-21%
2021
$1.7M
-19%
2022
$1.4M
+64%
2023
$2.3M
-15%
2024
$1.9M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 1 distinct procedure code. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$15.6M
3,959 claims
$3,948.36
$177.99
22.2×
Top 25%
Q5003Top 25%
Injection, infliximab-dyyb, biosimilar, 10 mg
$15.6M
3,959 claims · 100.0%
Your Cost: $3,948.36/claim|Median: $177.99
22.2× median